RAHWAY, N.J., June 23, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WINREVAIR ...

Amgen’s recently initiated 72-week phase 3 MariTide studies in weight management will randomize patients to one of three target doses, putting each group at an initial starting dose of 21 mg ...

The initial participant in the pivotal Phase 3 REVEAL trial, which is assessing ION582 for Angelman syndrome, a severe neurodevelopmental disease, has been dosed by Ionis Pharmaceuticals, Inc. ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but demonstrated fast-acting healing of the ocular surface, according to a ...

(RTTNews) - Compass Pathways plc (CMPS) announced Monday that its investigational psilocybin therapy, COMP360, met the primary endpoint in the Phase 3 COMP005 trial for treatment-resistant ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.. A total of 106 patients with ...

The ongoing Phase 3 COMP005 trial is the first study of an investigational, synthetic psilocybin, and the first classic psychedelic to report Phase 3 efficacy data.

3. Sweet Chili Mango Complete Salad Kit, $3.99 for 11 ounces. I’m well-acquainted with this salad kit. It’s the base of my three-ingredient stir-fry.The cruciferous base cooks down easily in a ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt.

As this Phase 3 trial progresses, Compass is also running an additional, larger Phase 3 trial with 568 planned participants and a different study protocol. Here, people will be given either psilocybin ...

The decision to phase out manual electricity meter readers comes amid growing public frustration over inflated power bills, which officials say are often the result of inaccurate manual readings.